Treatment of Kawasaki Syndrome
- 7 August 1986
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 315 (6) , 388-390
- https://doi.org/10.1056/nejm198608073150608
Abstract
Mucocutaneous lymph node syndrome (Kawasaki syndrome) is an acute febrile syndrome of unknown origin recognized predominantly in children under nine years of age. The disease was first recognized as a clinical entity in Japan in 1961, by Tomisaku Kawasaki, who reported it in 1967.1 However, Kawasaki syndrome has now been recognized throughout the world. Local geographic and temporal clustering of cases has been reported frequently.Because the first cases were seen in Japanese children and American children of predominantly Japanese background, Kawasaki syndrome was initially presumed to occur most commonly in the Japanese. That assumption has not been disproved. The . . .Keywords
This publication has 4 references indexed in Scilit:
- The Treatment of Kawasaki Syndrome with Intravenous Gamma GlobulinNew England Journal of Medicine, 1986
- Kawasaki Syndrome: An UpdateHospital Practice, 1982
- Kawasaki Disease: A ‘New’ Pediatric EnigmaHospital Practice, 1978
- RICKETTSIA-LIKE BODIES AND SPLENITIS IN KAWASAKI DISEASEThe Lancet, 1976